Full Description
International case-studies on regulation and science collaboration show how competition and economic pressures on the national regulators of biomedicine condition the development of jurisdictive regulations. But regulation that fails to guarantee a jurisdiction's optimal protection of patients and scientific research in favour of other interests commits foreseeable and avoidable "regulatory violence". Even when well-intended, regulation gets caught up in the intense international competition to support public health and generate national wealth, with real-world implications. Evidence from Asia, Europe and the USA challenges the belief that regulation improves ethical practices in regenerative medicine, connects practitioners with good science, and protects patient safety. This book explains why this is so, and points to ways in which science could help us address healthcare issues in greater solidarity. This title is also available as Open Access on Cambridge Core.
Contents
1. Regulatory violence and beyond - regenerative medicine and competitive desire; Part I. Regulatory Capitalism: 2. Regulatory boundary-work in a Global Arena of regulatory capitalism; 3. Regulatory capacity building: regulatory orientations and life-science innovation in LMICs; Part II. Regulatory Immunity: 4. Regulatory immunity and immune tolerance in regenerative medicine; 5. Regulatory capital in International scientific collaboration - a Japanese-Thai science collaboration in regenerative medicine; Part III. Regulatory Redemption: 6. Regulatory redemption and the all Japan system: when the spirit of the regulation is not reflected in its reforms; 7. The Internationalisation of health Organisations - The inadequacy of redemptive down-regulation; Part IV. Regulatory Brokerage and Its Regulatory Violence: 8. Regulatory brokerage and regulatory cascades; 9. Beyond regulatory violence - caring solidarity; References; Appendix; Index.
